Summary
In order to investigate the influence of lithium long-term medication on serotonergic neurotransmission, fenfluramine stimulation (FFS) was used for the assessment of hormonal effects under serotonergic control. The cortisol plasma concentration following FFS was examined between 8 a.m. and 1 p.m. in 11 manic-depressive subjects under lithium prophylaxis and in 8 untreated euthymic patients. In addition, 11 healthy subjects with FFS, and 12 other subjects without FFS were investigated. The basal cortisol concentrations show considerable variation. Those of the lithium patients were in general found lower than those of the control groups. In both, the controls and the manic-depressive patients without lithium medication, no gross deviation from the expected physiological decline of morning cortisol values was found. A subtle effect of FFS in healthy subjects could be observed. In the lithium patients, however, a significant inversion of the cortisol secretion pattern with a steep increase between 10 and 12 a.m. could be demonstrated. It is concluded that FFS and lithium long-term medication exert an agonistic influence onto central serotonergic neurotransmission. Pharmacological challenge with fenfluramine may prove to be a useful tool for the investigation of serotonergic mechanisms in biological psychiatry.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abluwalia, P., Singhai, R. L.: Monoamine up-take into synaptosomes from various regions of rat brain following lithium administration and withdrawl. Neuropharmacol.20, 483–487 (1981).
Aghajanian, G. K., Wang, R. Y.: Physiology and pharmacology of central serotonergic neurons. In: Psychopharmacology: A Generation in Progress (Lipton, A., Di Mascio, A., Killam, K. F., eds.), pp. 171–183. New York: Raven Press. 1978.
Bereits, S. C., Wolff, J.: Lithium Research and Therapy, pp. 443–445. London-New York-San Francisco. 1975.
Blundell, J. E., Leshem, M.: Central action of anorexic agents: Effects of amphetamine and fenfluramine in rats with lateral hypothalamic lesions. European J. Pharmacol.28, 81–83 (1974).
Born, G. V. R., Grignani, G., Martin, K.: Long-term effect of lithium on the up-take of 5-hydroxytryptamine by human platlets. Br. J. Pharmacol.9, 321–325 (1980).
Broderick, P., Lynch, V.: Behavioral and biochemical changes induced by lithium and L-tryptophan in muricidal rats. Neuropsychopharmacol.21, 671–679 (1982).
Brown, G. L., Goodwin, F. K., Ballenger, J. C., Goyer, P. F., Major, L. F.: Aggression in human correlates with cerebrospinal fluidamine metabolites. Psychiat. Res.1, 131–139 (1979).
Brown, G. L., Ebert, M. H., Goyer, P. F., Jimerson, D. C., Klein, W. J., Bunney, W. E., Goodwin, F. K.: Aggression, suicide, and serotonin: Relationships in CSF amine metabolites. Am. J. Psychiat.139, 741–746 (1982).
Bunney, W. E., Garland, B. L.: Possible receptor effects of chronic lithium administration. Neuropharmacol.22, 367–372 (1983).
Charney, D. S., Heninger, G. R., Reinhard, J. F., Sternberg, D. E., Hafstead, K. M.: The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects. Psychopharmacol.78, 38–43 (1982).
Charney, D. S., Heninger, G. R., Sternberg, D. E.: Serotonin fonction and mechanism of action of antidepressant treatment. Arch. Gen. Psychiatr.41, 359–365 (1984).
Clineschmidt, B. V., Zacchei, A. G., Totaro, J. A., Pflueger, A. B., McGuffin, J. C., Wishousky, Th. I.: Fenfluramine and brain serotonin. Ann. N.Y. Acad. Sci.305, 222–241 (1978).
Cockson, J., Silverstone, T.: 5-hydroxytryptamine and dopamine pathways in mania. A pilot study of fenfluramine and pimozide. Br. J. Pharmacol.3, 942–947 (1976).
Coppen, A., Swade, C., Wood, K.: Lithium restores abnormal platlet 5-HT-transport in patients with affective disorders. Br. J. Psychiat.136, 235–238 (1980).
Corona, G. L., Cucchi, M. L., Santagostino, G., Frattini, P., Zerbi, F., Fenoglio, L., Savoldi, F.: Blood noradrenaline and 5-HT levels in depressed women during amitriptyline and lithium treatment. Psychopharmacol.77, 236–241 (1982).
Czernik, A., Kleesiek, K.: Neuroendokrinologische Veränderungen unter Langzeitbehandlung mit Lithiumsalzen. Pharmacopsychiat.12, 305–312 (1979).
De Montigny, C., Tan, A. T., Caille, G.: Short-term lithium enhances 5-HT neurotransmission in rat administered chronic antidepressant treatments. Presented at Society for Neuroscience, 11th Annual Meeting, Los Angeles, p. 646 (1981).
De Montigny, C., Cournoyer, G., Morisette, R., Langlois, R.: Lithium carbonate addition ot tricychc antidepressant-resistant unipolar depression. Arch. Gen. Psychiat.40, 1327–1334 (1983).
Duhault, J., Beregi, L., Du Boistesselin, R.: General and comparative pharmacology of fenfluramine. Curr. Med. Res. Opin.6, 3–14 (1979).
Duhault, J., Malen, Ch., Boulanger, M., Voisin, C., Beregi, L., Schmitt, H.: Fenfluramine and 5-hydroxytryptamine. Arzneim.-Forsch./Drug Res.25, 1755–1762 (1975).
Eroglu, L., Atamer-Simsek, S.: Effect of lithium on stress-induced changes in brain levels of monoamines in rats. Arzneim.-Forsch./Drug Res.30, 2115–2117 (1980).
Fink, M., Shapiro, D. M., Itil, T. M.: EEG-profiles of fenfluramine, amobarbital, and dextroamphetamine in normal volunteers. Psychopharmacol.22, 369–383 (1971).
Friedman, E., Dallob, A., Gershon, L.: The effect of lithium long-term treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmission. Life Sci.25, 1263–1266 (1979).
Garattini, S., Jori, A., Buczko, W., Samanin, R.: The mechanism of action of fenfluramine. Postgrad. Med. J.51, 27–35 (1975).
Garattini, S., Samanin, R.: Anorectic drugs and brain neurotransmitter. In: Appetite and food intake (Silverstone, T., ed.), pp. 83–108. (Dahlem Workshop on Appetite and Food-intake.) Berlin: Abakon Verlagsgesellschaft. 1976.
Halmi, K. A., Noyes, R., Millard, S. A.: Effect of lithium on plasma cortisol and adrenal response to adrenocorticotropin in man. Clin. Pharmacol. Ther.13, 699–703 (1978).
Harrison-Read, P. E.: Evidence from behavioural reactions to fenfluramine, 5-hydrox-tryptophan, and 5-methoxy-N, N-dimethyltryptamine for differentia effects of short-term and long-term lithium on indoleaminergic mechanisms in rats. Br. J. Pharmacol.66, 144–145 (1979).
Heninger, G. R., Charney, D. S., Sternberg, D. E.: Lithium carbonate augmentation of antidepressant treatment. Arch. Gen. Psychiat.40, 1335–1342 (1983).
Heninger, G. R., Charney, D. S., Sternberg, D. E.: Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch. Gen. Psychiat.41, 398–402 (1984).
Knapp, S., Mandell, A. J.: Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: Effects of fenfluramine. J. Pharmacol. Exp. Ther.198, 123–132 (1976).
Knapp, S., Mandell, A. J.: Lithium and chlorimipramine differentially alter bilateral asymmetry in mesocortical serotonin metabolites and kinetic conformation of midbrain tryptophan hydroxylase with respect to tetrahydrobiopterin cofactor. Neuropharmacol.19, 1–7 (1979).
Lerer, B., Ebstein, R. B., Felix, A., Belmaker, R. H.: Lithium amelioration of reserpine-induced hypoactivity in rats. Int. Pharmacopsychiat.15, 338–343 (1980).
Mandell, A. J., Knapp, S.: A neurobiological model for the symmetrical prophylactic action of lithium in bipolar affective disorder. Pharmacopsychiat.9, 116–126 (1976).
Mandell, A. J., Knapp, S.: Asymmetry and mood, emergent properties of serotonin regulation. Arch. Gen. Psychiat.36, 909–916 (1979).
Maggi, A., Enna, S. J.: Regional alteration in rat brain neurotransmitter systems following chronic lithium treatment. J. Neurochem.34, 888–892 (1980).
Meltzer, H. Y., Witta, B., Tricou, B. J., Simonovic, M., Fang, V., Manov, G.: Effects of serotonin precursors and serotonin agonists on plasma hormone levels. In: Serotonin in Biological Psychiatry (Ho, B. T., Schoolar, J. C., Usdin, E., eds.), pp. 117–139. Raven Press. 1982.
Meltzer, H. Y., Arora, R. C., Baber, R., Tricou, B. J.: Serotonin uptake in blood platelets of psychiatric patients. Arch. Gen. Psychiat.38, 1322–1326 (1981).
Meltzer, H. Y., Arora, R. C., Goodnick, P.: Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders. J. Affect. Disorders5, 215–221 (1983).
Meltzer, H. Y., Lowy, M., Robertson, A., Goodnick, P., Perline, R.: Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. Arch. Gen. Psychiat.41, 391–397 (1984).
Mühlbauer, H. D.: Human aggression and the role of central serotonin. Pharmacopsychiat. (in press).
Mühlbauer, H. D., Hardt, W.: The influence of lithium salts and antidepressive medication on the serum prolactin level. Pharmacopsychiat.13, 213–217 (1980).
Mühlbauer, H. D., Graef, K. J., Müller-Oerlinghausen, B.: Neuroendokrine Aspekte der Lithium-Prophylaxe. In: Biologische Psychiatrie (Beckmann, H., ed.), p. 211–217. Stuttgart: G. Thieme. 1981.
Mühlbauer, H. D., Müller-Oerlinghausen, B.: The fenfluramine test: A simple tool for investigations on lithium-induced changes of serotonergic neurotransmission in manic-depressive patients. Arzneim.-Forsch./Drug Res.32, 897 (1982).
Mühlbauer, H. D., Müller-Oerlinghausen, B.: Veränderungen der serotonergen Neurotransmission bei manisch-depressiven Patienten unter Lithium-Prophylaxe. In: Forschungen zur Biologischen Psychiatrie (Hopf, A., Beckmann, H., eds.), pp. 192–197. Berlin-Heidelberg-New York-Tokyo: Springer. 1984.
Müller, E. E., Nisticó, G., Scapagnini, U.: Neurotransmitters and Anterior Pituitary Function. New York-San Francisco-London: Academic Press. 1977.
Müller-Oerlinghausen, B.: Lithium long-term medication-does it act via serotonin? Pharmacopsychiat. (in press).
Müller-Oerlinghausen, B., Bauer, H., Girke, W., Kanowski, S., Goncalves, N.: Impairment of vigilance and performance under lithium treatment. Studies in patient and normal volunteers. Pharmakopsychiat.10, 67–78 (1977).
Murphy, D. L., Colburn, R. W., Davis, J. M., Bunney, W. E.: Stimulation by lithium of monoamine uptake in human platelets. Life Sci.8, 1187–1193 (1969).
Murphy, D. I., Slater, S., De la Vega, C. E., Lipper, S.: The serotonergic neurotransmitter system in the affective disorders-a preliminary evaluation of the antidepressant and antimanic effects of fenfluramine. In: Neuropsychopharmacology (Demker, P., Thomas-Radouko, C., Villeneuve, A., eds.), pp. 675–682. Oxford: Pergamon Press. 1978.
Orosco, M., Bremond, J., Jacquot, C., Cohen, Y.: Fenfluramine and brain transmitter in the obese zucker rat. Neuropharmacol.23, 183–188 (1984).
Pearce, J. B.: Fenfluramine in mania. Lancet1, 800, 427 (1973).
Platman, St. R., Fieve, R. F.: Lithium carbonate and plasma cortisol response in the affective disorders. Arch. Gen. Psychiat.18, 591–594 (1968).
Platman, S. R., Hilton, J. G., Koss, M. C.: Production of cortisol in patients with manic-depressive psychosis treated with lithium carbonate. Dis. Nerv. Syst.32, 542–544 (1971).
Poitou, P., Guerinot, F., Bohoun, C.: Effect of lithium on central metabolism of 5-hydroxytryptamine. Psychopharmacol.38, 75 (1974).
Rommelspacher, H., Strauss, S.: Effect of lesions of raphe nuclei on the activity of catecholaminergic and serotonergic neurones in various brain regions of the ratin vivo. J. Neural Transm.49, 51–62 (1980).
Sangdee, C., Franz, D. N.: Lithium enhancement of central 5-HT transmission induced by 5-HT precursors. Biol. Psychiat.15, 59–75 (1980).
Schubert, J.: Effects of chronic lithium treatment on monoamine metabolism in rat brain. Psychopharmacol.32, 301–311 (1973).
Steranka, L. R., Sanders-Bush, E.: Species differences in the rate of disappearance of fenfluramine and its effects on brain serotonin neurons. Biochem. Pharmacol.28, 3103–3107 (1979).
Swann, A. C., Heninger, G. R., Roth, R. H., Maas, J. W.: Differential effects of short- and long-term lithium on tryptophan uptake and serotonergic function in cat brain. Life Sci.28, 347–354 (1981).
Sotelo, C., Zamora, A.: Lack of morphological changes in the neurons of the B 9 group in rats treated with fenfluramine. Curr. Med. Res. Opin.6, 55–62 (1978).
Treiser, S., Kellar, K. J.: Lithium: Effects on serotonin receptors in rat brain. Eur. J. Pharmacol.64, 183–185 (1980).
Yuwiler, A., Benett, B. L., Brammer, G. L., Geller, E.: Lithium treatment and tryptophan transport through the blood-brain barrier. Biochem. Pharmacol.28, 2709–2712 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mühlbauer, H.D., Müller-Oerlinghausen, B. Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man. J. Neural Transmission 61, 81–94 (1985). https://doi.org/10.1007/BF01253053
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01253053